Drugs / RotarixTM
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02538211 Comparator | Sep 2015 → Jan 2017 | Rotavirus infection, post-bacterial disorder, streptococcal pneumonia, tetanus | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RotarixTM | “All subjects will be given an oral dose of the rotavirus vaccine, RotarixTM, and intramuscular injections of the Tetanus vaccine and Pneumococcal vaccine, Pneumo 23.” NCT02538211 ↗ |
| Route | Oral | “an oral dose of the rotavirus vaccine, RotarixTM” NCT02538211 ↗ |